ATYR vs GIS · rev $190.0K vs P/E 8.2, rev $18.42B
aTyr Pharma, Inc. (ATYR) versus General Mills Inc (GIS) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Latest reported ATYR revenue for 2025-09-30 was $190.0K. Net income was -$25.7M. ATYR currently screens at market cap $471.7M.
Latest reported GIS revenue for 2026-05-31 was $18.42B. Net income was -$87.6M. Revenue was up 304.4% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
ATYR currently screens at market cap $471.7M. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Not investment advice. Open the ATYR and GIS stock pages for the full models.
Not investment advice.